You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HLA-A*0201/p53 aa264-272

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uveal Melanoma Trial in Worldwide (IMCgp100, Dacarbazine, Ipilimumab)

Active, not recruiting
Has Results
  • Uveal Melanoma
  • IMCgp100
  • +3 more
  • Los Angeles, California
  • +55 more
Mar 10, 2022

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)

Not yet recruiting
  • Glioma, Malignant
  • Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
  • Hiltonol
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University
Jan 19, 2023

Colorectal Cancer, Gastric Cancer, Pancreatic Cancer Trial in Huntersville, Canton (CUE-102)

Recruiting
  • Colorectal Cancer
  • +3 more
  • Huntersville, North Carolina
  • +1 more
Jul 5, 2022

Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)

Not yet recruiting
  • Oropharyngeal Cancer
  • +10 more
  • (no location specified)
Dec 14, 2022

Non Small Cell Lung Cancer Trial in Leiden, Rotterdam (TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51))

Recruiting
  • Non Small Cell Lung Cancer
  • TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51)
  • Leiden, Zuid-Holland, Netherlands
  • +1 more
Jun 1, 2023

Healthy Adult Volunteers Trial in Adelaide (DR-0201, Placebo)

Not yet recruiting
  • Healthy Adult Volunteers
  • Adelaide, South Australia, Australia
    Dren Investigational Site
Aug 18, 2023

Oropharyngeal Squamous Cell Carcinoma Trial in Saint Louis (CUE-101)

Recruiting
  • Oropharyngeal Squamous Cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 22, 2022

Human Immunodeficiency Virus Trial in Sweetwaters (A couples-focused intervention for HIV prevention and care in South Africa)

Recruiting
  • Human Immunodeficiency Virus
  • A couples-focused intervention for HIV prevention and care in South Africa
  • Sweetwaters, KwaZulu Natal, South Africa
    Human Sciences Research Council
May 3, 2022

Diffuse Midline Glioma, H3 K27M-Mutant Trial in San Francisco (Cyclophosphamide, Fludarabine, Autologous Anti-H3.3K27M

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • San Francisco, California
    University of California, San Francisco
Aug 15, 2022

Endometrial Cancer Trial (Vaginal brachytherapy, Adjuvant radiotherapy (EBRT +/- brachytherapy), Observation)

Not yet recruiting
  • Endometrial Cancer
  • Vaginal brachytherapy
  • +2 more
  • (no location specified)
Nov 29, 2022

Fragile X Syndrome Trial in Australia, United States (Sulindac (HLX-0201), dose strength 1, Sulindac (HLX-0201), dose strength

Withdrawn
  • Fragile X Syndrome
  • Sulindac (HLX-0201), dose strength 1
  • +3 more
  • Aurora, Colorado
  • +9 more
Dec 7, 2022

P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer

Completed
  • Endometrial Cancer
  • p 53 immunohistochemistry positive staining and relation to stages ,pathological types and grading
  • Alexandria, Egypt
    Hossam Hassan El Sokkary
Sep 13, 2022

Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Jul 5, 2023

Diffuse Large B Cell Lymphoma Trial in Wuhan (Zanubrutinib plus RCHOP)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Zanubrutinib plus RCHOP
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
Aug 16, 2023

Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Sep 15, 2023

Relapsing-remitting Multiple Sclerosis Trial (CT-P53, US-Ocrevus, EU-Ocrevus)

Not yet recruiting
  • Relapsing-remitting Multiple Sclerosis
  • CT-P53
  • +2 more
  • (no location specified)
Jun 7, 2023

Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations Trial in Guangzhou (Arsenic trioxide)

Not yet recruiting
  • Pediatric Cancer
  • +2 more
  • Arsenic trioxide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Oct 12, 2023

Obstetrical History and Anti-HLA Antibodies Level

Not yet recruiting
  • Blood Donors
  • Anti-HLA Antibody
  • Obstetrical history
  • Anti-HLA Antibody tests
  • Bordeaux, France
    Etablissement Français du Sang Nouvelle Aquitaine
Aug 25, 2023

Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, Selinexor-VRD)

Recruiting
  • Multiple Myeloma
  • Tianjin, China
    Institute of Hematology and Blood Diseases Hospital Chinese Acad
May 12, 2023

Solid Tumor Trial in Houston (Single Injection of IVS-3001- Anti - HLA-G CAR-T cells, Fludarabine phosphate, Cyclophosphamide)

Not yet recruiting
  • Solid Tumor
  • Single Injection of IVS-3001- Anti - HLA-G CAR-T cells
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in

Not yet recruiting
  • Head and Neck Cancer
  • +8 more
  • Tumor and HLA Profiling
  • (no location specified)
Mar 31, 2023

End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection Trial in Los Angeles (Donor CD34+,

Not yet recruiting
  • End Stage Kidney Disease
  • +3 more
  • Donor CD34+, CD3+. and belumosudil
  • Los Angeles, California
    University of California, Los Angeles
Apr 6, 2023

Breast Cancer Trial in United States (HKI-272, Surgical Resection, Capecitabine)

Active, not recruiting
  • Breast Cancer
  • San Francisco, California
  • +17 more
Jan 30, 2023

Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV Trial in Jerusalem (CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide,

Recruiting
  • Sarcoma, Synovial
  • +8 more
  • CYCLOPHOSPHAMIDE and FLUDARABIN
  • +3 more
  • Jerusalem, Israel
    Hadassah Medical Organization
Mar 15, 2022